{{Rsnum
|rsid=11465996
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Chromosome=8
|Orientation=plus
|Gene=LY96
|position=73989727
|Gene_s=LY96
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 43.1 | 44.6 | 12.3
| HCB | 57.8 | 40.0 | 2.2
| JPT | 86.4 | 11.4 | 2.3
| YRI | 66.7 | 33.3 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 57.8 | 40.0 | 2.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=24971461
|Title=Polymorphisms in the Inflammatory Pathway Genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG Are Associated with Susceptibility of Inflammatory Bowel Disease in a Danish Cohort
}}